Dosidal · Switzerland

Bupropion XR Sandoz, Retardtabletten

Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.

MarketSwitzerland
Recordch:authorisation:68628 (version 1)
Levelauthorisation
Pack codenot anchored
Identifiersswissmedic-authorisation: 68628
atc: N06AX12
Source authoritySwissmedic
Read date
authorisation statusfirst_authorisation: 2023-12-12
term: zugelassen
valid_until: 2028-12-11
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
identityatc: N06AX12
authorisation_number: 68628
form: RETT
holder: Sandoz Pharmaceuticals AG
holder_partner_nr: 1006431
it_number: 01.06.0.
name: Bupropion XR Sandoz, Retardtabletten
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
SignatureES256 over JCS, key dosidal-record-1.9dbf5d53
9jw8Hfm0Yp-n1Hs8_RAMG8tBRafEv04vlfQ4jNxRksJw0tioADXbfSOPnbkzBJx_6I6rQdN4K9jYGnQuAi0AbQ
Verify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json

JSON: https://dosidal-api.ai/v1/records/ch:authorisation:68628 · Related records in other markets · Dosidal